Johnson & Johnson has raised the prices of about two dozen drugs. Most of the increases were between 6% and 7%, and some of its top-selling drugs, such as psoriasis treatment Stelara, prostate cancer drug Zytiga, and blood thinner Xarelto, were included. A spokesman said the company does not plan to raise the prices of any additional drugs this year. (Reuters)
Louisiana has adopted a subscription model to pay for expensive hepatitis C drugs. Instead of paying for each prescription, the state will fork over a subscription fee to a drugmaker for unlimited access to the treatment, a method known as the “Netflix model.” (Washington Post) More info here: MM&M.
A drug pricing advocacy group has launched a $1 million ad campaign supporting President Donald Trump’s plan. The group, Patients for Affordable Drugs, is pushing Congress to support Trump’s proposal to align U.S. drug prices with those in other wealthy nations. Patients for Affordable Drugs spent $10 million during the midterms to support candidates working to lower prices and to oppose those that it thought were in bed with the pharma industry. (STAT)
The biggest increase in overdose deaths over the past two decades was among middle-aged women. New data from the CDC found overdoses among women ages 30 to 64 increased by 260% between 1999 and 2017. The increase in deaths from opioid overdoses was even higher among this group, rising 492%. (NBC News)
AbelsonTaylor has launched a video series focused on healthcare and technology. The series, called Icons Health, features conversations with the leaders of health and tech companies such as Microsoft, Aetna, Twitter, and Biogen. (AbelsonTaylor)